3,249 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 584 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,249
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
2901
$279K
2902
$279K
2903
$279K
2904
$279K
2905
$278K
2906
$278K
2907
$278K
2908
$277K
2909
$277K
2910
$277K
2911
$276K
2912
$276K
2913
$275K
2914
$275K
2915
$275K
2916
$275K
2917
$274K
2918
$274K
2919
$274K
2920
$273K
2921
$273K
2922
$273K
2923
$272K
2924
$272K
2925
$270K